Dataset Information

Cell maturation influences the ability of hESC-RPE to tolerate cellular stress.

ABSTRACT:

Background

Transplantation of human pluripotent stem cell-derived retinal pigment epithelium (RPE) is an urgently needed treatment for the cure of degenerative diseases of the retina. The transplanted cells must tolerate cellular stress caused by various sources such as retinal inflammation and regain their functions rapidly after the transplantation. We have previously shown the maturation level of the cultured human embryonic stem cell-derived RPE (hESC-RPE) cells to influence for example their calcium (Ca²⁺) signaling properties. Yet, no comparison of the ability of hESC-RPE at different maturity levels to tolerate cellular stress has been reported.

Methods

Here, we analyzed the ability of the hESC-RPE populations with early (3 weeks) and late (12 weeks) maturation status to tolerate cellular stress caused by chemical cell stressors protease inhibitor (MG132) or hydrogen peroxide (H₂O₂). After the treatments, the functionality of the RPE cells was studied by transepithelial resistance, immunostainings of key RPE proteins, phagocytosis, mitochondrial membrane potential, Ca²⁺ signaling, and cytokine secretion.

Results

The hESC-RPE population with late maturation status consistently showed improved tolerance to cellular stress in comparison to the population with early maturity. After the treatments, the early maturation status of hESC-RPE monolayer showed impaired barrier properties. The hESC-RPE with early maturity status also exhibited reduced phagocytic and Ca²⁺ signaling properties, especially after MG132 treatment.

Conclusions

Our results suggest that due to better tolerance to cellular stress, the late maturation status of hESC-RPE population is superior compared to monolayers with early maturation status in the transplantation therapy settings.

SUBMITTER: Viheriala T

PROVIDER: S-EPMC8785579 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:The duration and intensity of freezing stress are the most critical factors determining injury in autumn chickpeas, limiting their production and development. To evaluate the effects of freezing temperature and duration on the survival rate (SU%), as well as the physiological and biochemical characteristics of autumn chickpea seedlings, a study was conducted using five different temperatures (0, -6, -8, -10, and -12°C) and five different durations (1 h, 2 h, 3 h, 4 h, and 5 h) of exposure to freezing stress. The SU% of chickpea seedlings decreased to zero after exposure to temperatures of -10°C and -12°C for 5 hours. As the temperature decreased from -8°C to -12°C and the duration of exposure to freezing stress increased from 1 to 5 hours, the leaf membrane stability index decreased by 33%, 48%, 46%, 57%, and 58%, respectively. The highest and lowest total pigment contents were observed after 1 hour at 0°C and 5 hours at -12°C, respectively. The maximum photochemical efficiency of photosystem II (Fv'/Fm') was not affected by temperatures as low as -8°C in any of the time treatments during the recovery period. However, this parameter's value decreased as the freezing stress duration increased. At -12°C, the activity of ascorbate peroxidase, catalase, and peroxidase increased by 44.6%, 38.3%, and 33.0%, respectively, as the duration of stress was increased from 1 hour to 5 hours. A positive and significant correlation was observed between plant dry weight, membrane stability index, photosynthetic pigment content, and Fv'/Fm' with SU% after exposure to freezing stress. The minimum temperature and the maximum duration of freezing stress tolerance in chickpea seedlings were observed at -12°C for two hours. Our findings confirm that prolonging the freezing duration disrupts the defense mechanisms of chickpea seedlings. Therefore, future studies on breeding chickpeas tolerant to freezing stress should concentrate on attributes strongly correlated with SU%.

Project description:BackgroundHuman pluripotent stem cells (hPSCs) provide a promising cell source for retinal cell replacement therapy but often lack standardized cell production and live-cell shipment logistics as well as rigorous analyses of surgical procedures for cell transplantation in the delicate macula area. We have previously established a xeno- and feeder cell-free production system for hPSC differentiated retinal pigment epithelial (RPE) cells, and herein, a novel immunosuppressed non-human primate (NHP) model with a disrupted ocular immune privilege is presented for transplanting human embryonic stem cell (hESC)-derived RPE on a scaffold, and the safety and submacular graft integration are assessed. Furthermore, the feasibility of intercontinental shipment of live hESC-RPE is examined.MethodsCynomolgus monkeys were systemically immunosuppressed and implanted with a hESC-RPE monolayer on a permeable polyester-terephthalate (PET) scaffold. Microscope-integrated intraoperative optical coherence tomography (miOCT)-guided surgery, postoperative follow-up incorporated scanning laser ophthalmoscopy, spectral domain (SD-) OCT, and full-field electroretinography (ERG) were used as outcome measures. In addition, histology was performed after a 28-day follow-up.ResultsIntercontinental cell shipment, which took >30 h from the manufacturing to the transplantation site, did not alter the hESC-RPE quality. The submacular hESC-RPE xenotransplantation was performed in 11 macaques. The miOCT typically revealed foveal disruption. ERG showed amplitude and peak time preservation in cases with favorable surgical outcomes. Histology confirmed photoreceptor preservation above the grafts and in vivo phagocytosis by hESC-RPE, albeit evidence of cytoplasmic redistribution of opsin in photoreceptors and glia hypertrophy. The immunosuppression protocol efficiently suppressed retinal T cell infiltration and microglia activation.ConclusionThese results suggest both structural and functional submacular integrations of hESC-RPE xenografts. It is anticipated that surgical technique refinement will further improve the engraftment of macular cell therapeutics with significant translational relevance to improve future clinical trials.